Bio-engineering company Run3D spins-out from the University of Oxford.

Run3D, a new UK-based bio-engineering firm aimed at helping runners to avoid injury, has been spun out from the University of Oxford (UO).

Initial investment for Run3D has come from The Oxford Technology Combined Seed Enterprise Investment and Enterprise Investment Scheme Fund, managed by Oxford Technology Management, for an undisclosed sum. Other  partners include the University of Calgary, venture fund Technikos, which has a long term commercial partnership with UO’s Institute of Bio-medical engineering, and the Oxford University Hospitals NHS trust, which were involved with the incubation of the technology used by Run3D.

The firm will provide computerised three-dimensional assessment of a runner’s gait to prevent overuse injuries that affect half of all runners.

Run 3D chief executive officer Dr Jessica Leitch said, “Run3D’s unique and rigorous approach provides an objective and scientific service, which delivers an effective and evidence-based programme that is tailored very specifically to that individual.”


Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?